Published in Hepatology on October 01, 2015
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer (2016) 2.91
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma? Hum Gene Ther (2015) 1.25
Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma. Immunotherapy (2016) 0.96
Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res (2015) 0.93
Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol (2016) 0.80
Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription. World J Hepatol (2016) 0.79
Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis. Hepat Mon (2016) 0.78
Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort. World J Gastroenterol (2016) 0.77
Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma. Oncotarget (2016) 0.77
Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB. Int J Mol Med (2016) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Role of the microbiome in non-gastrointestinal cancers. World J Clin Oncol (2016) 0.76
Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma. Oncotarget (2016) 0.76
Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients. Ann Lab Med (2016) 0.76
MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. Sci Rep (2016) 0.76
Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis. World J Gastroenterol (2017) 0.75
Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment. Cancer Sci (2016) 0.75
Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget (2016) 0.75
pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population. Int J Mol Epidemiol Genet (2017) 0.75
Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge. J Hepatocell Carcinoma (2017) 0.75
Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation. Onco Targets Ther (2016) 0.75
Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa. Infect Agent Cancer (2017) 0.75
Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Cancer (2016) 0.75
Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. Carcinogenesis (2016) 0.75
Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions. Euro Surveill (2017) 0.75
Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma. Mol Cancer (2016) 0.75
Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues. Sci Rep (2017) 0.75
Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi. Am J Transl Res (2016) 0.75
The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression. Eur J Clin Microbiol Infect Dis (2016) 0.75
Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family. PLoS One (2017) 0.75
miRNA-346 promotes proliferation, migration and invasion in liver cancer. Oncol Lett (2017) 0.75
ShRNA knock-down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization. J Cell Mol Med (2017) 0.75
Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice. Oncotarget (2017) 0.75
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology (2012) 10.00
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology (2004) 8.36
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep (2012) 6.91
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med (2003) 6.06
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine (2012) 6.01
Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol (2014) 4.82
Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS. J Infect Dis (2005) 2.47
Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology (2012) 1.89
Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer (2007) 1.87
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology (2011) 1.74
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med (2014) 1.66
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis (2013) 1.65
Treating hepatitis C in lower-income countries. N Engl J Med (2014) 1.52
Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis (2011) 1.48
Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev (2006) 1.47
Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol (2002) 1.46
Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int (2011) 1.39
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology (2006) 1.31
A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Lett (2009) 1.15
Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments. World J Gastroenterol (2014) 1.10
Hepatocellular carcinoma in central Sydney:a 10-year review of patients seen in a medical oncology department. World J Gastroenterol (1999) 1.06
Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis (2013) 0.97
Risk of liver cancer among US male veterans with cirrhosis, 1969-1996. Br J Cancer (2012) 0.94
Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study. Aust N Z J Public Health (2007) 0.93
Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. Mayo Clin Proc (2012) 0.88
Both HCV and HBV are major causes of liver cancer in Southeast Asians. J Immigr Minor Health (2013) 0.85
Interferon-free hepatitis C treatment: one pill to fit all? Lancet (2013) 0.80
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am (2013) 1.74
Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer (2014) 1.50
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One (2016) 1.40
EUROGIN 2008 roadmap on cervical cancer prevention. Int J Cancer (2009) 1.00
Human papillomavirus vaccines and anal carcinoma. Curr Opin HIV AIDS (2009) 0.95
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. Int J Cancer (2015) 0.87
Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs. J Infect Dis (2015) 0.87
Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide. J Virol (2015) 0.84
Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era. J Infect Dis (2014) 0.83
Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer. Am J Otolaryngol (2013) 0.82
Type-specific human papillomavirus biological features: validated model-based estimates. PLoS One (2013) 0.82
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice. Int J Cancer (2017) 0.82
Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study. Lancet Oncol (2016) 0.82
Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer (2017) 0.80
Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya. PLoS One (2014) 0.79
Prevalence of HPV infection and other risk factors in a Fijian population. Infect Agent Cancer (2014) 0.78
Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR. J Clin Microbiol (2016) 0.78
Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer (2015) 0.77
Hepatitis C Virus Seroprevalence in Mongolian Women Assessed by a Novel Multiplex Antibody Detection Assay. Cancer Epidemiol Biomarkers Prev (2015) 0.76
Embryonic cells in the squamous-columnar junction of the cervix: scope for prophylactic ablation? Int J Cancer (2014) 0.76
Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study. Infect Agent Cancer (2016) 0.75
Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis (2017) 0.75
Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis. Int J Epidemiol (2015) 0.75
Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study. J Infect Dis (2017) 0.75
β- and γ-Human Papillomavirus Types and Smoking in Head and Neck Cancer. JAMA Oncol (2016) 0.75
Consumption of Fish Is Not Associated with Risk of Differentiated Thyroid Carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J Nutr (2017) 0.75
HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget (2017) 0.75
Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan. Oncotarget (2017) 0.75
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol (2020) 0.75
HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget (2017) 0.75
Prospects for primary prevention of cervical cancer in developing countries. Salud Publica Mex (2003) 0.75
Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study. PLoS One (2017) 0.75
Cervical screening: toward an equal risk/equal management approach, irrespective of HIV status. AIDS (2017) 0.75